Weight-Loss Drugs and Eye Health: What You Need to Know
TL;DR Summary
Recent studies suggest that GLP-1 agonist drugs like Ozempic and Wegovy, used for weight loss and diabetes management, may carry a small risk of serious eye conditions such as NAION and diabetic retinopathy, but the overall risk appears modest and requires further research. Patients with risk factors should consult their doctors and undergo regular eye exams to monitor eye health while on these medications.
- New Research Confirms Weight-Loss Drug Link With Sudden Vision Loss ScienceAlert
- Study Counters Others on GLP-1, Diabetic Retinopathy Link Medscape
- A warning about weight loss drugs and potential eye damage — and more WGN-TV
- Ozempic Vision Loss? What to Know About GLP-1 Drugs And Eyes TODAY.com
- Popular Diabetes Drugs Linked to Small Risk of Retinal, Optic Nerve Disorders MedPage Today
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
5 min
vs 5 min read
Condensed
94%
999 → 64 words
Want the full story? Read the original article
Read on ScienceAlert